Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
N Biotechnol ; 72: 29-37, 2022 Dec 25.
Artigo em Inglês | MEDLINE | ID: mdl-36049650

RESUMO

An annual External Quality Assurance (EQA) program has been provided to processing laboratories over the last ten years, allowing them to assess the performance of their processing methods, such as nucleic acid extractions or peripheral blood mononuclear cell (PBMC) isolation and cryopreservation. The objective of this study was to perform a global analysis on almost 1000 EQA scheme/participant data in order to assess (i) the impact of critical preanalytical factors on quantitative or qualitative attributes of different types of specimens and (ii) laboratory performance pattern over time. Statistical analysis was performed within each EQA scheme based on categorized preanalytical data provided by the participants and on centralized measurements of relevant quality attributes of the produced specimens (z-scores): DNA, cell-free (cf)DNA or RNA extraction from blood, DNA or RNA extraction from formalin fixed tissue, DNA or RNA extraction from frozen tissue, DNA extraction from saliva or stool, viable PBMC isolation and cryopreservation. The most critical preanalytical factors in nucleic acid extraction schemes were the nucleic acid extraction method and kit, the elution buffer, the enzymes used during extraction, the input material quantity and the storage temperature. Several indications of laboratory performance improvement over time could be seen. The conclusions are that EQA for processing methods provides unique evidence-based insights into the impact of preanalytical factors and the comparative performance of different processing methods and kits, while supporting laboratories in validating their processing methods.


Assuntos
Laboratórios , Leucócitos Mononucleares , Humanos , DNA , RNA
2.
Alzheimers Res Ther ; 10(1): 87, 2018 08 28.
Artigo em Inglês | MEDLINE | ID: mdl-30153863

RESUMO

BACKGROUND: In this study, we tested to which extent possible between-center differences in standardized operating procedures (SOPs) for biobanking of cerebrospinal fluid (CSF) samples influence the homogeneity of the resulting aliquots and, consequently, the concentrations of the centrally analyzed selected Alzheimer's disease biomarkers. METHODS: Proficiency processing samples (PPSs), prepared by pooling of four individual CSF samples, were sent to 10 participating centers, which were asked to perform aliquoting of the PPSs into two secondary aliquots (SAs) under their local SOPs. The resulting SAs were shipped to the central laboratory, where the concentrations of amyloid beta (Aß) 1-42, pTau181, and albumin were measured in one run with validated routine analytical methods. Total variability of the concentrations, and its within-center and between-center components, were analyzed with hierarchical regression models. RESULTS: We observed neglectable variability in the concentrations of pTau181 and albumin across the centers and the aliquots. In contrast, the variability of the Aß1-42 concentrations was much larger (overall coefficient of variation 31%), with 28% of the between-laboratory component and 10% of the within-laboratory (i.e., between-aliquot) component. We identified duration of the preparation of the aliquots and the centrifugation force as two potential confounders influencing within-center variability and biomarker concentrations, respectively. CONCLUSIONS: Proficiency processing schemes provide objective evidence for the most critical preanalytical variables. Standardization of these variables may significantly enhance the quality of the collected biospecimens. Studies utilizing retrospective samples collected under different local SOPs need to consider such differences in the statistical evaluations of the data.


Assuntos
Doença de Alzheimer/líquido cefalorraquidiano , Peptídeos beta-Amiloides/líquido cefalorraquidiano , Ensaio de Proficiência Laboratorial/normas , Fragmentos de Peptídeos/líquido cefalorraquidiano , Albuminas/líquido cefalorraquidiano , Biomarcadores/líquido cefalorraquidiano , Humanos , Fosforilação , Reprodutibilidade dos Testes , Proteínas tau/líquido cefalorraquidiano , Proteínas tau/metabolismo
3.
Biopreserv Biobank ; 14(5): 429-439, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27195612

RESUMO

Biobanks produce and distribute biospecimens, ensuring their fitness for purpose and accurately qualifying them before distribution. In their efforts toward professionalization, biobanks can nowadays seek certification or accreditation. One of the requirements of these standards is regular participation in Proficiency Testing (PT) programs. An international PT program has been developed and provided to biobanks and other laboratories that perform specific tests to qualify different types of biospecimens. This PT program includes biospecimen testing schemes, as well as biospecimen processing interlaboratory exercises. This PT program supports the development of biobank quality assurance by providing the possibility to assess biobank laboratory performance and useful insights into biobank laboratory method performance characteristics and thus fulfill the demands from accreditation authorities.


Assuntos
Bancos de Espécimes Biológicos/organização & administração , Manejo de Espécimes/normas , Acreditação , Bancos de Espécimes Biológicos/normas , Humanos , Controle de Qualidade
4.
J Microencapsul ; 30(7): 681-91, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23544878

RESUMO

CONTEXT: The release of an encapsulated drug is dependent on diffusion and/or degradation/erosion processes. OBJECTIVE: This work aimed to better understand the degradation mechanism of clonidine-loaded microparticles. METHODS: Gel permeation chromatography was used to evaluate the degradation of the polymer. The water-uptake and the weight loss were determined gravimetrically. The swelling behaviour and the morphological changes of the formulations were observed by microscopy. The glass transition temperature and the crystallinity were also determined by differential scanning calorimetry and X-ray diffraction, respectively. The pH of the medium and inside the microspheres was assessed. RESULTS: The microspheres captured a large amount of water, allowing a decrease in the molecular weight of the polymer. The pH of the medium decreased after release of the degradation products and the pH inside the microparticles remained constant due to the neutralization of these acidic products. CONCLUSION: Clonidine and buffers both had an action on the degradation.


Assuntos
Analgésicos/administração & dosagem , Clonidina/administração & dosagem , Portadores de Fármacos/química , Ácido Láctico/química , Ácido Poliglicólico/química , Soluções Tampão , Concentração de Íons de Hidrogênio , Microesferas , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Temperatura de Transição , Difração de Raios X
5.
Drug Dev Ind Pharm ; 39(11): 1731-41, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23078519

RESUMO

Inflammatory osteoarthritis (OA) is characterized by painful and destructive inflammatory flares of a single joint, mainly in the back, the knees, the wrists or the hips. Monoarthritis is generally treated by intraarticular (IA) injections of corticosteroids or hyaluronic acid (HA). However, due to their toxicity, the chronic use of corticosteroids should be avoided. The aim of this work was to develop a new slow-release formulation for a parenteral route of administration (e.g., IA). The development's strategy was based on the use of amphiphilic ingredients such as glyceryl monooleate (GMO), which is able to generate viscous crystalline phase structures upon contact with an aqueous fluid (e.g., synovial fluid) to sustain the drug activity over weeks. Clonidine (CLO) was suggested as a small and hydrophilic model drug and HA as a hydrophilic viscoelastic scaffold. Thermal analyses showed that the stability of GMO, HA, and CLO in mixtures with a ratio of 1:1 (wt/wt) was not affected in comparison with the raw materials. In order to obtain a formulation presenting suitable syringeability and containing GMO, CLO, and HA, two elements were found to be essential: a minimum of about 15% (wt/wt) water content and the use of co-solvents such as ethanol (ET) and propylene glycol (PG), approved by the FDA for parenteral use. Several developed gels presented pseudoplastic flow behavior. Moreover, the best composition provided an in vitro release of CLO for about 1 week that was similar to a cubic reference formulation, described by many authors as presenting poor syringeability but the best sustained-release capacity.


Assuntos
Analgésicos/química , Anti-Inflamatórios não Esteroides/química , Artrite/tratamento farmacológico , Clonidina/química , Excipientes/química , Glicerídeos/química , Modelos Moleculares , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/uso terapêutico , Artrite/imunologia , Fenômenos Químicos , Clonidina/administração & dosagem , Clonidina/uso terapêutico , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/química , Preparações de Ação Retardada/uso terapêutico , Combinação de Medicamentos , Composição de Medicamentos , Estabilidade de Medicamentos , Etanol/química , Géis , Humanos , Ácido Hialurônico/administração & dosagem , Ácido Hialurônico/química , Ácido Hialurônico/uso terapêutico , Injeções Intra-Articulares , Fenômenos Mecânicos , Propilenoglicol/química , Solubilidade , Solventes/química , Viscosidade
6.
Int J Pharm ; 437(1-2): 20-8, 2012 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-22903047

RESUMO

This work describes the encapsulation of a small, hydrophilic molecule (clonidine) into a PLGA matrix to provide sustained release over more than one month after intra-articular administration. The microparticles were prepared using a double emulsion (w(1)/o/w(2)) method followed by evaporation of the organic solvent. To optimize the efficiency of encapsulation and the mean size of the microparticles, which was targeted around 30 µm, the following parameters were modulated: the viscosity and the volume of the organic phase, the molecular weight of the polymer, the volume of the internal and external aqueous phases, the drug loading, the concentration of surfactant, and the stirring parameters. Blends of polymers characterized by different molecular weights (34000-96000 Da) as well as copolymers of PLGA-PEG were used to enhance the entrapment of the drug. The pH of the aqueous phases was adjusted to obtain suitable encapsulation efficiency. Characterization was made of the physico-chemical properties of the microparticles, such as their crystallinity (DSC and PXRD) and microstructure (SEM). When performing in vitro dissolution studies, controlled release for up to approximately 30 days was achieved with several of the formulations developed. Diffusion was found to be the dominant drug release mechanism at early time points.


Assuntos
Clonidina/química , Preparações de Ação Retardada/química , Ácido Láctico/química , Microesferas , Ácido Poliglicólico/química , Varredura Diferencial de Calorimetria , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Polietilenoglicóis/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Difração de Pó , Viscosidade , Difração de Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA